Overcoming HLA restriction in clinical trials
Open Access
- 4 November 2012
- journal article
- Published by Taylor & Francis Ltd in OncoImmunology
- Vol. 1 (8), 1392-1394
- https://doi.org/10.4161/onci.20926
Abstract
A decade of collective work by tumor immunologists has led to improved large scale generation, maturation, antigen loading and administration of dendritic cells (DCs) to cancer patients, promoting enhanced antitumor activity. We alleviated the HLA-restriction in DC therapy and demonstrated that it is meaningful to treat patients with DCs irrespective of their HLA type.Keywords
This publication has 10 references indexed in Scilit:
- Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4+ and CD8+ T Cells in Melanoma PatientsMolecular Therapy, 2012
- Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor TherapyCancer Research, 2012
- Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigensJournal of Immunological Methods, 2012
- Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patientCancer Immunology, Immunotherapy, 2011
- Therapeutic Vaccination With an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Advanced MelanomaJournal of Immunotherapy, 2011
- Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccinationProceedings of the National Academy of Sciences of the United States of America, 2010
- Suppression of Mature Dendritic Cell Function by Regulatory T Cells In Vivo Is Abrogated by CD40 LicensingThe Journal of Immunology, 2008
- Immunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical OutcomeJournal of Clinical Oncology, 2005
- Route of Immunization with Peptide-pulsed Dendritic Cells Controls the Distribution of Memory and Effector T Cells in Lymphoid Tissues and Determines the Pattern of Regional Tumor ControlThe Journal of Experimental Medicine, 2003
- Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic CellsScience, 2003